A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging Study
Year: 2008
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Blood
Institutions: Amsterdam UMC Location University of Amsterdam, University of Amsterdam, Maastricht University Medical Centre, Maastricht University, Care and Public Health Research Institute, University of Perugia, King's College London, Flinders Medical Centre, University of Oklahoma, University Hospital Carl Gustav Carus
Language: English
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2075359369
